Diagnostic value of pentraxin 3 in respiratory tract infections: A meta-analysis

Wu Ye1, Qing-Dong Huang, Ting-Yu Tang

  • 1Department of Respiratory Diseases, Zhejiang Hospital, Hangzhou, Zhejiang Province, People's Republic of China.

Medicine
|April 4, 2020
PubMed
Abstract

Insights

Pentraxin 3 shows moderate accuracy in diagnosing respiratory tract infections and ventilator-associated pneumonia. Bronchoalveolar lavage fluid levels offer superior diagnostic value compared to serum concentrations for these infections.

Area of Science:

  • Biochemistry
  • Medical Diagnostics
  • Infectious Diseases

Background:

  • Pentraxin 3 is an acute phase protein belonging to the long pentraxin subfamily.
  • It plays a role in the innate immune system response to inflammation.

Purpose of the Study:

  • To evaluate the diagnostic accuracy of Pentraxin 3 for respiratory tract infections through a meta-analysis.
  • To compare the diagnostic utility of Pentraxin 3 in different sample types, such as serum and bronchoalveolar lavage fluid (BALF).

Main Methods:

  • A systematic literature search was conducted across major databases (PubMed, Web of Knowledge, Cochrane Library).
  • Diagnostic performance metrics including sensitivity, specificity, likelihood ratios, and diagnostic odds ratio were pooled.
  • Summary receiver operator characteristic (SROC) curves and Q* values were calculated to assess overall accuracy.

Main Results:

  • The meta-analysis included 8 studies with 961 participants.
  • Pooled sensitivity and specificity for Pentraxin 3 in diagnosing respiratory tract infections were 0.78 and 0.73, respectively.
  • The area under the SROC curve was 0.84, with higher values for BALF (0.89) compared to serum (0.85). The diagnostic accuracy for ventilator-associated pneumonia (VAP) was 0.89.

Conclusions:

  • Pentraxin 3 demonstrates moderate diagnostic accuracy for respiratory tract infections and VAP.
  • Bronchoalveolar lavage fluid levels of Pentraxin 3 provide superior diagnostic value compared to serum concentrations.
  • Cutoff value was identified as a source of heterogeneity in diagnostic accuracy.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
710
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
669
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
190
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
757
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
215
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
431